Population
Patients with essential hypertension
Design
Review
Authors
Loading...
Supports aspirin restriction to high-risk hypertension; leaves open antiplatelet strategies for low-risk patients and alternatives like clopidogrel.
This review highlights the mechanisms of platelet activation in essential hypertension and emphasizes the need for long-term clinical outcome studies to clarify the role of antiplatelet agents, particularly in low-risk patients and with agents like clopidogrel.
Gkaliagkousi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: